Literature DB >> 2849968

Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.

J E Caldwell1, K P Castagnoli, P C Canfell, M R Fahey, D P Lynam, D M Fisher, R D Miller.   

Abstract

The pharmacokinetics of pipecuronium 0.07 mg kg-1 and pancuronium 0.1 mg kg-1 were compared in 39 ASA class I or II patients. Plasma concentrations of these agents were measured for 6 h following administration, using a sensitive and specific capillary gas chromatographic assay. Concentration v. time data were analysed by non-linear regression and fitted to a two- or three-compartment model as appropriate. Neuromuscular blockade was assessed by measuring the mechanical evoked response of the adductor pollicis muscle to train-of-four stimulation of the ulnar nerve. Pipecuronium had a larger steady-state volume of distribution (Vss) (309 (SD 103) ml kg-1) and greater plasma clearance (Cl) (2.4 (0.6) ml kg-1 min-1) than pancuronium (199 (54) ml kg-1 and 1.5 (0.4) ml kg-1 min-1, respectively). The volumes of the central compartment, distribution and elimination half-lives and mean residence times were similar for both agents and within the range expected for drugs of this type. The durations of action (injection to 25% recovery of twitch tension) of pipecuronium and pancuronium were similar: 98.0 (36.1) min and 117.2 (35.8) min, respectively. We conclude that the time courses of neuromuscular blockade following pipecuronium and pancuronium are similar, despite the differences in Vss and Cl.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849968     DOI: 10.1093/bja/61.6.693

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Pharmacokinetics of pipecuronium in infants, children and adults.

Authors:  E Tassonyi; J F Pittet; C N Schopfer; J C Rouge; G Gemperle; O H Wilder-Smith; D R Morel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jul-Sep       Impact factor: 2.441

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 4.  Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.

Authors:  R K Mirakhur
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

5.  Neuromuscular and cardiovascular effects of pipecuronium.

Authors:  F F Foldes; H Nagashima; H D Nguyen; D Duncalf; P L Goldiner
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

6.  A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients.

Authors:  P P Neidhart; P Champion; J Vogel; E K Zsigmond; E Tassonyi
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

Review 7.  New developments in nondepolarizing muscle relaxants.

Authors:  R K Mirakhur
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.